Home・Aandelen Lijst・Cytek Biosciences Inc

Cytek Biosciences Inc

Gesloten

SectorGezondheidszorg

4.22 1.44

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.09

Max

4.22

Belangrijke statistieken
By Trading Economics
Inkomsten	25M -19M
Verkoop	-18M 44M
EPS	-0.1
Winstmarge	-42.746
Werknemers	678
EBITDA	-14M -14M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+33.65% upside

Dividenden
By Acuity
Volgende Winsten	4 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-45M 557M
Vorige openingsprijs	2.78
Vorige sluitingsprijs	4.22

Nieuwssentiment

By Acuity

50%

151 / 340 Rangschikking in Healthcare

Cytek Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 aug 2026, 19:36 UTC

Cytek Biosciences Inc is higher today, supported by broader market gains amid expectations of a Federal Reserve pause on interest rate hikes.

6 aug 2026, 20:02 UTC

News

Cytek Biosciences raises 2026 revenue guidance to $207 million-$212 million, aligning with consensus. Shares are higher despite a mixed earnings report.

5 aug 2026, 22:02 UTC

News

Cytek Biosciences shares are lower in after-market hours following a second-quarter earnings miss and revenue that fell short of expectations.

4 aug 2026, 20:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting broader market trends after a notable early peak. Overall market performance has declined since Monday.

3 aug 2026, 19:56 UTC

Cytek Biosciences Inc. shares are higher today, reflecting broader market trends as major indices gain amid easing geopolitical tensions. No specific news was identified.

31 jul 2026, 19:26 UTC

Correlated Moves

Cytek Biosciences Inc shares are lower as first-quarter results show a significant decline, reflecting broader sector pressures amid rising bond yields.

30 jul 2026, 19:18 UTC

Cytek Biosciences Inc. shares are lower today, reflecting ongoing weakness and trading significantly below the 20-day moving average amid broader market volatility.

27 jul 2026, 19:56 UTC

Cytek Biosciences Inc is trading lower today, retracing from an early peak. The asset remains near the lower end of its one-month trading range.

24 jul 2026, 17:16 UTC

Cytek Biosciences Inc. shares are lower today, declining after an early peak. The asset remains below its 20-day moving average amid broader market volatility.

23 jul 2026, 19:46 UTC

Cytek Biosciences Inc. shares are trading roughly flat, reflecting limited movement since Wednesday. Earlier, shares peaked before retracing to current levels.

21 jul 2026, 19:06 UTC

Cytek Biosciences Inc shares are lower today, continuing a three-session decline amid broader market conditions. No specific news was identified to explain the movement.

20 jul 2026, 19:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting routine fluctuations near the upper end of their one-month trading range amid a broader market decline.

Peer Vergelijking

Prijswijziging

Cytek Biosciences Inc Prognose

Koersdoel

By TipRanks

33.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 5.56 USD 33.65%

Hoogste 7.5 USD

Laagste 4.75 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cytek Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Cytek Biosciences Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

151 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.